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Abstract
Introduction: The efficacy and the optimal type and volume of aerobic exercise (AE) in fibromyalgia syndrome (FMS) 
are not established. We therefore assessed the efficacy of different types and volumes of AE in FMS.
Methods: The Cochrane Library, EMBASE, MEDLINE, PsychInfo and SPORTDISCUS (through April 2009) and the 
reference sections of original studies and systematic reviews on AE in FMS were systematically reviewed. Randomised 
controlled trials (RCTs) of AE compared with controls (treatment as usual, attention placebo, active therapy) and head-
to-head comparisons of different types of AE were included. Two authors independently extracted articles using 
predefined data fields, including study quality indicators.
Results: Twenty-eight RCTs comparing AE with controls and seven RCTs comparing different types of AE with a total of 
2,494 patients were reviewed. Effects were summarised using standardised mean differences (95% confidence 
intervals) by random effect models. AE reduced pain (-0.31 (-0.46, -0.17); P < 0.001), fatigue (-0.22 (-0.38, -0.05); P = 
0.009), depressed mood (-0.32 (-0.53, -0.12); P = 0.002) and limitations of health-related quality of life (HRQOL) (-0.40 (-
0.60, -0.20); P < 0.001), and improved physical fitness (0.65 (0.38, 0.95); P < 0.001), post treatment. Pain was significantly 
reduced post treatment by land-based and water-based AE, exercises with slight to moderate intensity and frequency 
of two or three times per week. Positive effects on depressed mood, HRQOL and physical fitness could be maintained 
at follow-up. Continuing exercise was associated with positive outcomes at follow-up. Risks of bias analyses did not 
change the robustness of the results. Few studies reported a detailed exercise protocol, thus limiting subgroup 
analyses of different types of exercise.
Conclusions: An aerobic exercise programme for FMS patients should consist of land-based or water-based exercises 
with slight to moderate intensity two or three times per week for at least 4 weeks. The patient should be motivated to 
continue exercise after participating in an exercise programme.
Introduction
The key symptoms of fibromyalgia syndrome (FMS) are
chronic widespread (both sides, above and below waist
line, and axial skeletal) pain, fatigue, sleep disturbances
and tenderness on palpation [1]. The estimated preva-
lence of FMS in western countries ranges from 2.2 to
6.6% [2]. Comorbidities with other functional somatic
syndromes and mental disorders are common [3]. FMS is
associated with high utilisation and costs of health ser-
vices. Effective treatment options are therefore needed
for medical and economic reasons [4].
Systematic reviews and evidence-based guidelines pro-
vide healthcare professionals and patients with a guide
through the great variety of pharmacological and non-
pharmacological treatment options in FMS. Three evi-
dence-based guidelines available on the management
gave different grades of recommendation for aerobic
exercises (AE) (aerobic exercise with and without addi-
tional strength and flexibility training) in FMS. The
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American Pain Society [5] and the guidelines of the Asso-
ciation of the Scientific Medical Societies in Germany [6]
gave the highest grade of recommendation for AE. The
European League Against Rheumatism judged the pub-
lished evidence for the efficacy of AE to be lacking [7].
Qualitative reviews on the efficacy of AE in FMS that
searched the literature until December 2006 came to dif-
ferent conclusions on the short-term and long-term effi-
cacy of AE in FMS [8-10].
More recently, Jones and Lipton reviewed over 70 FMS
exercise studies and found similar results when protocols
included yoga, tai chi and other movement-based thera-
pies [11]. Two meta-analyses on exercise in FMS have
been conducted. Busch and colleagues searched the liter-
ature until July 2005. Owing to significant clinical hetero-
geneity among the studies, only six studies with AE were
meta-analysed. Moderate quality evidence was found that
AE had positive effects on global well-being and physical
function, but not on pain at post treatment [12]. The
Ottawa Panel searched the literature until December
2006 and found most improvements for pain relief and
increase of endurance at post treatment [13]. Outcomes
at follow-up were not meta-analysed.
Not only the question of efficacy but also that of the
dose and type of AE need to be clarified. The American
Pain Society recommended encouraging patients to per-
form moderately intense AE (60 to 70% of age-adjusted
predicted maximum heart rate (maxHR)) two or three
times per week [5]. The evidence of this recommendation
has not been tested by meta-analyses of head-to-head
comparisons of different types and volumes of AE. More-
over, the question of whether continuing AE is required
to maintain a symptom reduction had not been systemat-
ically addressed.
The aims of the present systematic review were to
update the literature on AE in FMS and to assess whether
AE has beneficial effects at post treatment and at follow-
u p  o n  t h e  k e y  d o m a i n s  o f  F M S  ( p a i n ,  s l e e p ,  f a t i g u e ,
depressed mood), compared with other therapies. In con-
trast to the Cochrane review [12], we intended to meta-
analyse the outcomes of all randomised controlled trials
(RCTs) available. Another aim was to asses which types,
volumes and intensities of AE are effective by performing
head-to-head comparisons of RCTs with different types
and intensities of AE. The final aim was to assess whether
ongoing exercise is necessary to maintain potential posi-
tive effects of AE.
Materials and methods
The present review was performed according to the Pre-
ferred Reporting Items for Systematic Reviews and Meta-
Analyses statement [14] and the recommendations of the
Cochrane Collaboration [15].
Protocol
Methods of analysis and inclusion criteria were specified
in advance. We used the review protocol of our system-
atic review on multicomponent therapy in FMS [16].
Eligibility criteria
Types of studies
A RCT design comparing AE with a control group receiv-
ing no treatment, treatment as usual, attention control or
any pharmacological or nonpharmacological therapy, or
with head-to-head comparisons of different types or
intensities of AE were included. Studies without ran-
domisation were excluded.
Types of participants
Patients of any age diagnosed with FMS on recognised
criteria were included.
Types of intervention
AE was assumed if the reported target heart rate of the
training protocol was at least (on average) 40% of maxHR
or if the training protocol included exercise involving at
least one-sixth of the skeletal muscles (for example, walk-
ing, running, biking, aerobics, vibrations). At least 50% of
the training session should consist of AE. In the case of
mixed exercise, defined as a combination of AE with
stretching and/or muscle strength [17], the length of AE
should exceed the time with other types of exercise.
Stretching during warm-up and cool-down periods was
not defined as mixed exercise. No restrictions on fre-
quency or duration of training were made.
We excluded studies or study arms in which AE was
part of multicomponent therapy defined as a combina-
tion of AE with psychological therapy (structured educa-
tion or relaxation therapy, cognitive-behavioural therapy)
[16]. We excluded studies or study arms with balneother-
apy (warm-water treatment without exercise).
Types of outcomes measures
Studies should assess at least one key domain of FMS
(pain, sleep, fatigue, depressed mood and health-related
quality of life (HRQOL)) (primary outcome measures).
Secondary outcome measures were any measure of physi-
cal fitness.
Data sources and searches
The electronic bibliographic databases screened included
the Cochrane Central Register of Controlled Trials (CEN-
TRAL), EMBASE, MEDLINE, PsychInfo and SPORT-
DISCUS (through 31 March 2009). The search strategy
for MEDLINE is detailed in Additional file 1. The search
strategy was adapted for each database as necessary. No
language restrictions were made. Only fully published
papers were reviewed. In addition, reference sections of
original studies, systematic reviews [8-10] and evidence-
based guidelines on the management of FMS [4-6] were
screened manually.Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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Study selection
The search was conducted by two authors (PK, JL). Two
authors screened the titles and the abstracts of potentially
eligible studies identified by the search strategy detailed
above independently (PK, JL). The full-text articles were
then examined independently by two authors to deter-
mine whether they met the selection criteria (MSc, JL).
Discrepancies were rechecked and consensus was
achieved by discussion. If needed, two other authors
reviewed the data to reach a consensus (AB, WH).
Data collection process
Two authors independently extracted the data using stan-
dard extraction forms [16] (BM, MSc). Discrepancies
were rechecked and consensus was achieved by discus-
sion. If needed, a third author reviewed the data to reach
a consensus (WH).
Based on our experiences of former systematic reviews
in which none of the contacted authors provided these
details on request, we did not ask for clarifications of
study design in case of unclear randomisation, blinding or
concealment of treatment allocation. We searched for
further details of the study design in a Cochrane review
[12].
When means or standard deviations (SDs) were miss-
ing, attempts were made to obtain these data through
contacting 12 trial authors. Additional data were pro-
vided by four authors (see Tables 1 and 2). Where SDs
were not available from the trial authors, they were calcu-
lated from t  values, confidence intervals or standard
errors when reported in articles [15]. If only the median
was given, the median was used instead of the mean and a
SD was substituted that was calculated as the mean of the
SDs available for studies that used the same outcome
scale.
Data items
The data for the study setting, participants, exclusion cri-
teria, interventions, co-therapies, attendance rates, side
effects reported and outcomes sought are presented in
Tables 2 and 3.
When researchers reported more than one measure for
an outcome, we used a predefined order of preference for
analysis (details available on request).
If studies had two or more potential control groups, we
used the following order to select for control group: treat-
ment as usual, attention placebo, and active control to
select the control group.
Risk of bias in individual studies
To ascertain the internal and external validity of the eligi-
ble RCTs, two pairs of reviewers (BM, WH; and MSc,
Mst) working independently and with adequate reliability
determined the adequacy of randomisation, concealment
of allocation, blinding of outcome assessors and adequacy
of data analysis (was intention-to-treat-analysis per-
formed?) (internal validity). Furthermore we chose the
item 'Were patients with mental disorders frequently
associated with FMS (depressive and anxiety disorders)
included in the studies?' as the marker of external validity.
Summary measures
Meta-analyses were conducted using RevMan Analyses
software (RevMan 5.0.17) from the Cochrane collabora-
tion [18]. Standardised mean differences (SMDs) were
calculated by means and SDs or change scores for each
intervention. The SMD used in Cochrane reviews is the
effect size known as Hedge's (adjusted) g [15]. Examina-
tion of the combined results was performed by a random
effects model (inverse variance method), because this
model is more conservative than the fixed effects model
and incorporates both within-study and between-study
variance [19]. We used Cohen's categories to evaluate the
magnitude of the effect size, calculated by the SMD: g >
0.2 to 0.5, small effect size; g > 0.5 to 0.8, medium effect
size; g > 0.8, large effect size [20].
Planned methods of analysis
Heterogeneity was tested using the I2 statistic, with I2 >
50% indicating strong heterogeneity. τ2 was used to deter-
mine how much heterogeneity was explained by sub-
group differences [15].
Risk of bias across studies
Potential publication bias - that is, the association of pub-
lication probability with the statistical significance of
study results - was investigated using visual assessment of
the funnel plot (plots of effect estimates against its stan-
dard error) calculated by RevMan Analyses software.
Publication bias may lead to asymmetrical funnel plots
[15]. Moreover, we checked a potential small sample size
bias by a sensitivity analysis of studies with very small
(<25), small (25 to 50) and medium (>50) sample sizes.
Additional analyses
Subgroup analysis
The following subgroup analyses were pre-specified:
types of AE (land-based, water-based and mixed; AE as
monotherapy or combined with flexibility and/or
strength), intensity of AE (very low intensity, <50% of
maxHR; low intensity, 50 to 60% of maxHR; moderate
intensity, 60 to 80% maxHR; intensity left up to patient),
frequency of AE per week (1 time/week, 2 times/week, 3
times/week and >3 times/week), duration of the study (<7
weeks, 7 to 12 weeks, >12 weeks) and duration of total
aerobic exercise (<1,000 minutes, 1,000 to 2,000 minutes,
>2,000 minutes), and type of control group (attention pla-
cebo, treatment as usual, other active therapy). These
subgroup analyses were also used to examine potential
sources of clinical heterogeneity.Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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Table 1: Risk of bias (internal and external validity) of the randomised controlled trials' analysis
Author, year Adequate 
randomisation
Adequate 
allocation 
concealment
Blinding of 
assessor
Intention-to-treat 
analysis
Inclusion of 
patients with 
mental disorders
Alentorn, 2008 0 0 + - +
Altan, 2004 0 0 0 - -
Assis, 2006 + + - + -
Bircan, 2006 0 0 0 - +
Buckelew, 2008 0 0 0 - +
Da Costa, 2005 + + + + +
Ecvik, 2008 0 0 0 - +
Etnier, 2009 0 0 0 - +
Fontaine, 2007 0 0 0 - +
Gowans, 2001 0 0 0 - +
Gusi, 2006 0 0 0 - -
Jentoft, 2001 0 0 - + +
Jones, 2008 + + + + -
King, 2002 + 0 + + +
Martin, 1996 0 0 + + +
McCain, 1988 0 0 + - +
Mengshoel, 1992 + 0 0 + +
Meyer, 2000 0 0 0 - +
Munguia, 2008 + + + + -
Nichols, 1994 0 0 0 - +
Noregaard, 1997 0 0 0 + +
Ramsay, 2000 0 0 + + 0
Redondo, 2004 + 0 0 + -
Richards, 2002 + + + + +
Rooks, 2007 + + + + 0
Schachter, 2003 + + + + +
Sencan, 2004 0 0 0 + 0
Stephens, 2008 + + + + +
Tomas-Carus, 
2008
0++ + 0
Valim, 2003 0 0 + + +
Valkeinen, 2008 + 0 0 + 0
Van Santen, 2001 0 - - - 0
Van Santen, 2002 0 0 + + -
Vitorino, 2006 + + - + -
Wigers, 1996 0 0 + + 0
+, yes; 0, unclear; -, no.Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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Sensitivity analyses
The following sensitivity analyses were pre-specified:
inadequate or unclear versus adequate sequence genera-
tion; inadequate or unclear allocation versus adequate
concealment; intention-to-treat analysis, no versus yes;
studies that provided medians of outcomes versus means
of outcomes; and patients with mental disorders fre-
quently associated with FMS excluded (yes or unclear).
These sensitivity analyses were also used to examine
potential sources of methodological heterogeneity.
Results
Study selection
The literature search produced 464 citations, of which
292 were double hits (study found in at least two data
sources). By screening, 110 records were excluded: 23
evaluated AE, but not in FMS; 19 did not evaluate AE in
Table 2: Effect sizes of aerobic and mixed exercise on selected outcome variables
Outcome title Number of 
study arms
Number of 
patients on 
aerobic exercise
Effect sizea Test for overall 
effect P value
Heterogeneity, I2; 
τ2 (%)
Post treatment
01 Pain 29 567 -0.31 (-0.46, -0.17) <0.001 26; 0.03
02 Fatigue 16 364 -0.22 (-0.38, -0.05) 0.009 9; 0.01
03 Sleep 9 184 0.01 (-0.19, 0.21) 0.92 0; 0
04 Depressed 
mood
19 456 -0.32 (-0.53, -0.12) 0.002 51; 0.10
05 HRQOL 25 526 -0.40 (-0.60, -0.20) <0.001 63/0.15
06 Physical 
fitness
20 339 0.65 (0.38, 0.93) <0.001 71/0.20
Latest follow-up
01 Pain 9 187 -0.13 (-0.80, 0.54) 0.08 0/0
02 Fatigue 4 93 -0.23 (-0.62, 0.17) 0.26 42/0.07
03 Sleep 4 84 0.17 (-0.14, 0.47) 0.28 0/0
04 Depressed 
mood
8 151 -0.44 (-0.88, 0.01) 0.05 71/0.22
05 HRQOL 8 221 -0.27 (-0.48, -0.05) 0.02 14/0.01
06 Physical 
fitness
5 99 0.65 (0.35, 0.96) <0.001 0/0
HRQOL: health-related quality of life. aStandardised mean difference (95% confidence interval).
Table 3: Effect sizes of head-to-head comparisons of different types of aerobic exercise on selected outcome variables
Outcome title 
post treatment
Number of 
studies
Number of 
patients
Effect sizea Test for overall 
effect, P value
Heterogeneity, I2;
 τ2 (%)
Moderate intensity versus low intensity
01 Pain 2 68 -0.08 (-1.41, 1.26) 0.91 78; 0.96
02 Depressed 
mood
2 68 -0.16 (-0.67, 0.13) 0.53 0; 0.
03 Physical 
fitness
2 68 0.25 (-0.26, 0.75) 0.34 0; 0
Land-based versus water based exercise
01 Pain 9 187 -0.13 (-0.80, 0.54) 0.08 0/0
02 Depressed 
mood
8 151 -0.44 (-0.88, 0.01) 0.05 71/0.22
aStandardised mean difference (95% confidence interval).Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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FMS; 52 were review articles; and 18 were case reports or
commentaries. Sixty of the full-text articles assessed for
eligibility, and 25 full-text articles were excluded for the
following reasons: two for publication of different out-
comes of one trial in two publications [21,22]; six for lack-
ing a control group [23-28]; three for lacking
randomisation [29-31]; two because one could not con-
clude from the study protocol that the exercises per-
formed met the predefined criteria of AE [32,33]; one
because two different types of water-based exercise with
similar intensity were compared [34]; one because the
study did not assess a primary outcome measure [35]; and
10 because AE was combined with education or psycho-
therapy or pharmacotherapy [36-45]. Three RCTs com-
paring different intensities of AE [46-48], four RCTs
comparing land-based with water-based exercise [49-52]
and 28 RCTs with 29 study arms comparing AE with con-
trols [53-80] were included in the qualitative and quanti-
tative analyses (see Figure 1).
Study characteristics
Setting, referral and exclusion criteria (representativeness of 
study samples)
Fourteen studies each were conducted in North America,
13 studies in Europe and four studies each in South
America (Brazil) and Asia (Turkey) (see Additional files 1,
2 and 3). Patients were recruited by register of hospitals,
referral (general practitioner, rheumatologist, hospital
departments), local self-help groups and newspaper
advertisement. Thirty-two studies were conducted within
the setting of a university, three within district hospitals.
All studies were single-centre based. One study had two
AE study arms.
Thirty-one studies excluded patients with internal dis-
eases or with orthopaedic diseases precluding AE. Six-
teen studies excluded patients with mental disorders
including depression. Four studies excluded patients with
unresolved litigation. No study reported comorbidities of
the patients.
Participants
The median of the mean age of the participants was 45
years (13 to 59 years). One study included only children
and adolescents. The median of the percentage of women
was 100% (71 to 100%).
Interventions
AE was supervised by a trainer in 32 studies. AE included
cycling, walking, aquatic jogging, games, dance and
rhythmic or boxing movements. Aerobic intensity was
reported in 27 studies as a target heart rate or percentage
age-predicted maxHR determined by standard equations.
Percentage maxHRs were usually progressive and ranged
from 40 to 80% of the age-predicted maximum. The tar-
get heart rate of 21 studies was between low and moder-
ate intensity (50 to 80%). Only one study prescribed a
very low intensity (maxHR 30 to 50%), and three studies
recommended that patients should exercise with a mod-
erate intensity subjectively determined by the patient
without measuring the heart rate. Three studies did not
report the recommended intensity.
Sixteen studies reported the attrition rates, with a
median of 67% (range 27 to 90%).
In 12 studies the controls received treatment as usual,
and in 10 studies they received another active therapy
(spa, hot packs, structured education, supervised relax-
ation, cognitive behavioural therapy, muscle strengthen-
ing, stretching). In six studies an attention control was
used (nonstructured education, supervised recreational
therapies, transcutaneous electrical neurostimulation or
pharmacological placebo) (see Additional file 1).
Three studies compared different intensities of land-
based AE, and four studies compared water-based AE
with land-based AE (see Additional file 2).
A total 694/889 (78.1%) of the patients in the AE groups
and 617/742 (83.1%) in the control groups completed
therapy (z = -0.3, P = 0.7).
Fourteen studies performed follow-ups. The median of
the latest follow-up was 26 (12 to 208) weeks. Five studies
reported that the patients were motivated to continue
exercise [51,56,70,71,75]. One study recommended no
exercise until follow-up evaluation [61]. Two studies
assessed the effects of continuing exercise on outcomes
[25,80]. One study compared the outcomes of continuers
of exercise versus noncontinuers at follow-up without
mentioning whether continuing exercise had been rec-
ommended [80]. Two studies performed an uncontrolled
follow-up [37,60].
Outcomes
There was a great variety of most outcomes measures
(see Additional files 1, 2 and 3). Eleven studies reported
on side effects. Five studies reported that no side effects
occurred, and six studies reported an increase of symp-
toms leading to a drop out in some cases. Only six
p a t i e n t s  a s s i g n e d  t o  A E  w e r e  d e s i g n a t e d  t o  h a v e  a n
adverse event possibly related to exercise (metatarsal
stress fracture, plantar fasciitis, ischialgia, transient knee
pain).
Risk of bias within studies
Only two studies fulfilled all predefined criteria of inter-
nal and external validity (see Table 1).
Results of individual studies
The means, SDs, sample sizes and effect estimates of each
study can be seen in the forest plots (see Additional files
4, 5, 6, 7, 8, 9, 10, 11, 12 and 13).
Synthesis of results
Aerobic exercise patients versus controls
Data are reported as the SMD (95% confidence interval).Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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At post treatment, AE reduced pain (-0.31 (-0.46, -
0.17); P < 0.001), fatigue (-0.22 (-0.38, -0.05); P = 0.006),
depressed mood (-0.32 (-0.53, -0.12); P = 0.002) and limi-
tations of HRQOL (-0.40 (-0.60, -0.20); P < 0.001), and
improved physical fitness (0.65 (0.38, 0.93); P < 0.001),
compared with controls. The effect on sleep (0.01 (-0.19,
0.21); P = 0.92) was not significant. Based on Cohen's cat-
egories, the effects were small for pain, fatigue, depres-
sion and HRQOL, and were medium for physical fitness
(see Table 4).
At latest follow-up, AE reduced depressed mood (-0.44
(-0.88, 0.01); P = 0.05) and limitations of HRQOL (-0.27 (-
0.48, -0.05); P = 0.01), and improved physical fitness (0.65
(0.35, 0.96); P  < 0.001), compared with controls. The
effects were small for depressed mood and HRQOL, and
were medium for physical fitness. The effects on pain (-
0.13 (-0.80, 0.54); P = 0.08), fatigue (-0.23 (-0.62, 0.17); P =
0.26) and sleep (0.17 (-0.14, 0.47); P = 0.26) were not sig-
nificant (see Table 4).
Land-based versus water-based aerobic exercise
There were no significant effects of water-based AE ver-
sus land-based AE on the outcomes pain and depressed
mood at post treatment (see Table 2).
Moderate-intensity versus low-intensity aerobic exercise
There were no significant effects of moderate-intensity
compared with low-intensity AE on the outcomes pain,
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart. Schematic description of the results of the literature 
search.
Search of electronic databases
204 Cochrane
  96   Embase
134 Medline
       5 PsychInfo
       25 SportDiscus
0 of additional records 
identified by other 
searches
172 of records after duplicates removed
172 of records screened 110 of records excluded
60 of full-text articles as-
sessed for egilibility
25 Excluded:
   2  Double publication
6  No control group
3 No  randomisation
2  Pool therapy without aerobic exercise
1  No primary outcomes assessed
1 Two different types of water-based exer-
cise
10 Aerobic exercise combined with educa-
tion or psychotherapy or pharmacotherapy
35 of studies included in 
qualitative synthesis
35 of studies included in 
meta-analysisHäuser et al. Arthritis Research & Therapy 2010, 12:R79
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Table 4: Subgroup analysis for the effect size on pain at post treatment
Outcome title Number of 
study arms
Number of 
patients on AE
Effect sizea Test for overall 
effect, P value
Heterogeneity, I2; 
τ2 (%)
Type of exercise
Land-based 22 463 -0.29 (-0.46,-0.13) 0.0005 27; 0.03
Water-based 3 61 -0.67 (-1.04,-0.29) 0.0005 0; 0
Mixed 4 43 -0.03 (-0.45,0.39) 0.89 0; 0
Type of exercise
AE only 12 273 -0.35 (-0.61,-0.09) 0.0008 48; 0.09
AE combined 
with other 
exercise
17 294 -0.28 (-0.45,-0.15) 0.001 0; 0
Duration of study
<7 weeks 2 32 -1.16 (-1.86,-0.48) 0.001 36; 0.09
7 to 12 weeks 13 194 -0.24 (-0.50,-0.02) 0.03 16; 0.02
>12 weeks 12 338 -0.24 (-0.40,-0.08) 0.004 0; 0
Frequency of 
training/week
1 time/week 2 37 -0.07 (-0.54,03.9) 0.48 Not applicable
2 times/week 5 127 -0.69 (-0.95,-0.27) 0.0004 35; 0.06
3 times/week 16 241 -0.35 (-0.62,-0.09) 0.009 48; 0.10
>3 times/
week
4 142 -0.13 (-0.38, 0.13) 0.33 2; 0
Total duration 
aerobic exerciseb
<1,000 
minutes
10 175 -0.47 (-0.86,-0.08) 0.02 62; 0.19
1,000 to 
2,000 
minutes
9 175 -0.36 (-0.59,-0.13) 0.002 0; 0
>2,000 
minutes
8 217 -0.15 (-0.34, 0.05) 0.15 0; 0
Intensity of AEc
<50% maxHR 1 37 -0.09 (-0.54, 0.36) Not applicable Not applicable
Left up to 
patient
2 79 -0.42 (-0.77, -0.07) 0.02 0; 0
> 50% 
maxHR
21 367 -0.26 (-0.42,-0.11) 0.0007 0; 0
Type of control 
group
Attention 
placebo
7 229 -0.27 (-0.62, 0.07) 0.12 67; 0.12
Therapy as 
usual
10 147 -0.47 (-0.71,-0.24) <0.0001 0; 0
Active 
therapy
10 191 -0.27 (-0.49,-0.06) 0.01 0; 0
AE, aerobic exercise; maxHR, maximum of age-adjusted maximum heart rate. aStandardised mean difference (95% confidence interval). bIf no 
precise duration of AE was given, 50% of the total exercise time was assumed for aerobic exercise. cStudies that did not report the intensity 
of training were excluded from analysis.Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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depressed mood and physical fitness at post treatment
(see Table 3).
Effects of continuing exercise
One study found that continuers of exercise at follow-up
reported less pain and depression than those who did not
exercise [80]. One study found that exercising at follow-
up was related to improvements in physical function and
mood [37]. One study reported that pain returned close
to the pretraining level during the subsequent de-training
[61].
Risk of bias across studies
There was only substantial heterogeneity in the compari-
sons of depressed mood and HRQOL at post treatment
and for depressed mood at latest follow-up (see Table 2).
On visual inspection, the funnel plots of the outcomes
post treatment were symmetrical and were thus not
indicative for a publication bias (see Additional file 14).
Studies with small sample sizes had no significant effect
on pain at post treatment (see Table 5).
Additional analyses
Subgroup analysis
Subgroup analyses according to the types of AE, fre-
quency, total time and intensity of AE and type of control
groups did not change the significant effect of AE on pain
at post treatment, except for a combination of water-
based and land-based AE, total duration of AE >2,000
minutes, frequency of training 1 or >3 times/week and
intensity <50% maxHR and attention placebo as control.
Statistical heterogeneity of analysis for the effect size for
pain was substantially increased in the case of a total
duration of AE <1,000 minutes and attention placebo as
control (see Table 4).
Sensitivity analysis
Sensitivity analyses according to potential risks of bias for
the outcome pain at post treatment did not change the
significant effect of AE on pain at post treatment, except
for studies with sample size <25 and with only median of
outcomes available. Statistical heterogeneity of analysis
for the effect size for pain was substantially increased in
the case of studies that included patients with mental dis-
orders and with only the median of outcomes available
(see Table 5).
Discussion
Summary of evidence
AE reduces pain, fatigue and depressed mood, and
improves HRQOL and physical fitness, at post treatment.
Positive effects of AE on depressed mood, HRQOL and
physical fitness can be detected at latest follow-up. AE
has no positive effect on sleep at post treatment, and on
pain, fatigue and sleep at follow-up. Continuing exercise
is necessary to maintain positive effects on pain.
The following statements are valid for pain reduction at
post treatment. There is no evidence of a superiority of
water-based over land-based exercise. AE with a slight to
moderate intensity is effective. Low-intensity AE (<50%
m ax H R )  is  n o t  e f f ect i v e .  A  f r eq u e n cy  o f  AE  o f  2  t o  3
times/week for at least 4 to 6 weeks is necessary for a
reduction of symptoms. Combining AE with stretching
or strengthening is no more effective than AE alone.
The evidence is applicable to the majority of patients in
clinical practice except patients with internal and ortho-
paedic diseases that may prevent AE and male patients.
Limitations
Although every effort was made to obtain missing data
(outcomes, study design) from the trial authors, it was
not possible in every case to obtain these data; the
included studies are therefore not represented fully in the
meta-analyses. Only medians were available for three
studies, but excluding these studies from analysis did not
change the results.
The exercise protocol was insufficiently reported by
some trials. The positive effects of the training can there-
fore possibly be attributed to other forms of exercise such
as strength, stretching or relaxation, or in the case of
pool-based exercise to the effects of warm water. Sub-
group analyses did not, however, show a superiority of
mixed exercise versus aerobic exercise nor a superiority
of pool-based exercise versus land-based exercise.
The prescribed training intensity was either not
assessed by heart rate telemetry or was not reported. No
definitive conclusions on an effective intensity of AE are
therefore possible.
The attendance rates during the study were inconsis-
tently reported. If continuation of exercise until follow-up
was recommended was inconsistently reported too. A
subgroup analysis of studies with and without recom-
mended exercise at follow-up was thus not possible.
Side effects were inconsistently reported. No definitive
statement on the safety of AE in FMS is therefore possi-
ble.
The methodological quality of the studies varied. The
positive effect on pain, however, was robust against
potential methodological biases.
Given that formal blinding of participants and clini-
cians to the treatment arm is not possible in trials of exer-
cise, we could have underestimated the extent to which
clinicians' and participants' knowledge of group assigna-
tion influenced the true effect.
Males and adolescents were rarely included in the study
populations. As no gender comparisons were reported,
the evidence for the efficacy of AE in men and adoles-
cents with FMS is limited.Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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Agreements and disagreements with other systematic 
reviews
Our meta-analysis does not confirm the conclusion of a
qualitative systematic review that the greatest effects
o c c u r r e d  i n  e x e r c i s e  p r o g r a m m e s  t h a t  w e r e  o f  l o w e r
intensity than those of higher intensity [13]. Our data that
AE reduces pain at post treatment are in line with the
conclusion of the meta-analyses of the Ottawa Panel [13]
and are in contrast to that of the Cochrane review [12].
Not only moderate-intensity AE as recommended by the
American Pain Society [5], but also low-intensity AE
seems to be effective in reducing pain.
Conclusions
Implications for clinical practice
The amount and intensity of initial AE should be adapted
to the individual level of physical fitness. Patients should
start at levels just below their capacity and gradually
increase the duration and intensity until they are exercis-
ing with low to moderate intensity for 20 to 30 minutes 2
to 3 times/week [12]. It does not seem necessary to assess
the heart rate during AE to find the optimum intensity.
Patients should exercise with an intensity at which they
are able to speak fluently with another person [17]. The
choice of the type of AE should be left to the patient's
Table 5: Sensitivity analysis for the effect size on pain at post treatment
Outcome title Number of 
study arms
Number of 
patients on 
aerobic exercise
Effect sizea Test for overall 
effect, P value
Heterogeneity, I2; 
τ2 (%)
Adequate 
sequence 
generation
Adequate 11 251 -0.20 (-0.38, -0.01) 0.04 0; 0
Unclear or 
nonadequate
18 348 -0.39 (-0.61, -0.18) 0.0004 39; 0.07
Allocation 
concealment
Adequate 8 223 -0.24 (-0.47, -0.01) 0.04 24; 0.02
Unclear or 
nonadequate
19 344 -0.35 (-0.54, -0.16) 0.0002 28; 0.04
Blinding of 
assessor
Yes 12 306 -0.20 (-0.36,-0.03) 0.02 0; 0
No or unclear 15 261 -0.41 (-0.66,-0.16) 0.001 38;0.08
ITT analysis
Yes 13 315 -0.22 (-0.39, -0.06) 0.009 0; 0
No 14 252 -0.39 (-0.62, -0.16) 0.001 36; 0
Adequacy of 
outcomes for 
meta-analysis
Yes (means) 24 517 -0.35 (-0.51,-0.19) <0.0001 28;0.04
No (medians) 3 43 -0.05 {-0.43,-0.32) 0.78 0; 0
Sample size
<25 3 30 -0.33 (-1.00,0.33) 0.33 34; 0.12
25 to 50 15 188 -0.41 (-0.70,-0.13) 0.005 46;0.11
>50 9 349 -0.23 (-0.39,-0.08) 0.004 0; 0
Patients with 
mental disorders 
included
Yes 16 312 -0.43 (-0.78, -0.08) 0.02 73; 0.28
No or unclear 14 315 -0.40 (-0.61, -0.19) 0.0002 38; 0.05
ITT, intention to treat. aStandardised mean difference (95% confidence interval).Häuser et al. Arthritis Research & Therapy 2010, 12:R79
http://arthritis-research.com/content/12/3/R79
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preferences and comorbidities and to the local offers of
AE [11]. A training programme should last a minimum of
4 weeks. Patients should be educated that they may have
some tolerable short-term increases in pain and fatigue
but, if they exercise at an appropriate intensity, these
symptoms should return to baseline levels within the first
few weeks of exercise [12,17]. Patients should be moti-
vated to continue exercise if they perceive a reduction of
symptoms after the programme.
Because AE does not reduce sleeping disturbances, a
combination of AE with medication effective for improv-
ing sleep - for example, tricyclic or dual antidepressants
or pregabalin [81,82] - should be considered.
Implications for research
Four main questions need to be answered by future stud-
ies. By which methods (for example, education, booster
sessions) can patients be motivated to continue exercise?
Is aerobic and mixed exercise cost-effective [83]? Is the
combination of AE with pharmacological therapy supe-
rior to AE or medication alone? Which sociodemo-
graphic and clinical variables predict a positive and
negative treatment outcome?
Future studies on these topics should focus on larger
sample sizes (multicentre studies including a sufficient
number of men and adolescents and patients with mental
and somatic comorbidities). Study quality could be
improved by detailed reporting of demographic and clini-
cal data of the study groups at baseline, exercise protocol
and adherence to interventions (attendance rates, adher-
ence to prescribed intensity assessed by heart rate telem-
etry), creation of a standardised protocol to report
adverse events and use of standard outcome measures.
Additional material
Additional file 1 Search strategy for MEDLINE. The file contains the liter-
ature search strategy for the database MEDLINE.
Additional file 2 Main characteristics of studies with aerobic and 
mixed exercise in fibromyalgia syndrome. The file contains the main 
characteristics of studies with aerobic and mixed exercise in fibromyalgia 
syndrome including outcomes measures.
Additional file 3 Main characteristics of studies with head to head 
comparisons of different types of aerobic and mixed exercise in fibro-
myalgia syndrome. The file contains the main characteristics of studies 
with head-to-head comparisons of different types of aerobic and mixed 
exercise in fibromyalgia syndrome including outcome measures.
Additional file 4 Effect estimates (standardised mean differences) of 
aerobic exercise versus controls on pain at post treatment. Forest plots 
show standardised mean differences (effect sizes) from the random effects 
model (inverse variance method). A negative effect indicates that the end-
point score of the outcome in the exercise groups is lower than in control 
group in the study. The pooled (all studies together) effect size is weighted 
by the inverse variance of each study. IV, inverse variance (method); SD, 
standard deviation; Std. mean difference, standardised mean differences; 
random, random effects model; SD, standard deviation; total, number of 
patients; weight, relative weight (%) of the study in the calculation.
Additional file 5 Effect estimates (standardised mean differences) of 
aerobic exercise versus controls on fatigue and sleep at post treat-
ment. Forest plots show standardised mean differences (effect sizes) from 
the random effects model (inverse variance method). A negative effect indi-
cates that the endpoint score of the outcome in the exercise groups is 
lower than in control group in the study. The pooled (all studies together) 
effect size is weighted by the inverse variance of each study. IV, inverse vari-
ance (method); SD, standard deviation; Std. mean difference, standardised 
mean differences; random, random effects model; SD, standard deviation; 
total, number of patients; weight, relative weight (%) of the study in the cal-
culation.
Additional file 6 Effect estimates (standardised mean differences) of 
aerobic exercise versus controls on depressed mood at post treat-
ment. Forest plots show standardised mean differences (effect sizes) from 
the random effects model (inverse variance method). A negative effect indi-
cates that the endpoint score of the outcome in the exercise groups is 
lower than in control group in the study. The pooled (all studies together) 
effect size is weighted by the inverse variance of each study. IV, inverse vari-
ance (method); SD, standard deviation; Std. mean difference, standardised 
mean differences; random, random effects model; SD, standard deviation; 
total, number of patients; weight, relative weight (%) of the study in the cal-
culation.
Additional file 7 Effect estimates (standardised mean differences) of 
aerobic exercise versus controls on quality of life at post treatment. 
Forest plots show standardised mean differences (effect sizes) from the ran-
dom effects model (inverse variance method). A negative effect indicates 
that the endpoint score of the outcome in the exercise groups is lower than 
in control group in the study. The pooled (all studies together) effect size is 
weighted by the inverse variance of each study. IV, inverse variance 
(method); SD, standard deviation; Std. mean difference, standardised mean 
differences; random, random effects model; SD, standard deviation; total, 
number of patients; weight, relative weight (%) of the study in the calcula-
tion.
Additional file 8 Effect estimates (standardised mean differences) of 
aerobic exercise versus controls on physical fitness at post treatment. 
Forest plots show standardised mean differences (effect sizes) from the ran-
dom effects model (inverse variance method). A negative effect indicates 
that the endpoint score of the outcome in the exercise groups is lower than 
in control group in the study. The pooled (all studies together) effect size is 
weighted by the inverse variance of each study. IV, inverse variance 
(method); SD, standard deviation; Std. mean difference, standardised mean 
differences; random, random effects model; SD, standard deviation; total, 
number of patients; weight, relative weight (%) of the study in the calcula-
tion.
Additional file 9 Effect estimates (standardised mean differences) of 
aerobic exercise versus controls on pain and fatigue at latest follow-
up. Forest plots show standardised mean differences (effect sizes) from the 
random effects model (inverse variance method). A negative effect indi-
cates that the endpoint score of the outcome in the exercise groups is 
lower than in control group in the study. The pooled (all studies together) 
effect size is weighted by the inverse variance of each study. IV, inverse vari-
ance (method); SD, standard deviation; Std. mean difference, standardised 
mean differences; random, random effects model; SD, standard deviation; 
total, number of patients; weight, relative weight (%) of the study in the cal-
culation.
Additional file 10 Effect estimates (standardised mean differences) of 
aerobic exercise versus controls on sleep and depressed mood at lat-
est follow-up. Forest plots show standardised mean differences (effect 
sizes) from the random effects model (inverse variance method). A negative 
effect indicates that the endpoint score of the outcome in the exercise 
groups is lower than in control group in the study. The pooled (all studies 
together) effect size is weighted by the inverse variance of each study. IV, 
inverse variance (method); SD, standard deviation; Std. mean difference, 
standardised mean differences; random, random effects model; SD, stan-
dard deviation; total, number of patients; weight, relative weight (%) of the 
study in the calculation.Häuser et al. Arthritis Research & Therapy 2010, 12:R79
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